ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-22O12279
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Gastroesophageal Reflux Disease GERD Drugs and Devices Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Research Report 2025

Code: QYRE-Auto-22O12279
Report
June 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astrazeneca plc
Addex Therapeutics
Takeda Pharmaceutical Company Limited
Rottapharm (Meda AB)
Pfizer Inc
Eisai Co Ltd
The Procter& Gamble Company
Mederi Therapeutics
Aros Pharma
Torax Medical, Inc.
BD
EndoGastric Solutions
Medigus

Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market

Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market

The global market for Gastroesophageal Reflux Disease (GERD) Drugs and Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Gastroesophageal Reflux Disease (GERD) Drugs and Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastroesophageal Reflux Disease (GERD) Drugs and Devices.
The Gastroesophageal Reflux Disease (GERD) Drugs and Devices market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastroesophageal Reflux Disease (GERD) Drugs and Devices companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Report

Report Metric Details
Report Name Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AstraZeneca, Plc., Addex Therapeutics, Takeda Pharmaceutical Company Limited, Rottapharm (Meda AB), Pfizer, Inc., Eisai Co. Ltd., The Procter & Gamble Company, Mederi Therapeutics, Aros Pharma, Torax Medical, Inc., BD, EndoGastric Solutions, Medigus Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gastroesophageal Reflux Disease (GERD) Drugs and Devices company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market report?

Ans: The main players in the Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market are AstraZeneca, Plc., Addex Therapeutics, Takeda Pharmaceutical Company Limited, Rottapharm (Meda AB), Pfizer, Inc., Eisai Co. Ltd., The Procter & Gamble Company, Mederi Therapeutics, Aros Pharma, Torax Medical, Inc., BD, EndoGastric Solutions, Medigus Ltd.

What are the Application segmentation covered in the Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market report?

Ans: The Applications covered in the Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market report are Heartburn, Acid reflux disorders

What are the Type segmentation covered in the Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market report?

Ans: The Types covered in the Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market report are Medication, Minimally Invasive Surgery, Invasive Surgery

Recommended Reports

Digestive System Devices

Medical Device Software

Cardiac and Diagnostic Devices

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Medication
1.2.3 Minimally Invasive Surgery
1.2.4 Invasive Surgery
1.3 Market by Application
1.3.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Heartburn
1.3.3 Acid reflux disorders
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Perspective (2020-2031)
2.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Growth Trends by Region
2.2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Historic Market Size by Region (2020-2025)
2.2.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Region (2026-2031)
2.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Dynamics
2.3.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Industry Trends
2.3.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Drivers
2.3.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Challenges
2.3.4 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players by Revenue
3.1.1 Global Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players by Revenue (2020-2025)
3.1.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Players (2020-2025)
3.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue
3.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Concentration Ratio
3.4.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in 2024
3.5 Global Key Players of Gastroesophageal Reflux Disease (GERD) Drugs and Devices Head office and Area Served
3.6 Global Key Players of Gastroesophageal Reflux Disease (GERD) Drugs and Devices, Product and Application
3.7 Global Key Players of Gastroesophageal Reflux Disease (GERD) Drugs and Devices, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Breakdown Data by Type
4.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Historic Market Size by Type (2020-2025)
4.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Type (2026-2031)
5 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Breakdown Data by Application
5.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Historic Market Size by Application (2020-2025)
5.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2020-2031)
6.2 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2020-2025)
6.4 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2020-2031)
7.2 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2020-2025)
7.4 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2020-2031)
8.2 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (2020-2025)
8.4 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2020-2031)
9.2 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2020-2025)
9.4 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2020-2031)
10.2 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2020-2025)
10.4 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca, Plc.
11.1.1 AstraZeneca, Plc. Company Details
11.1.2 AstraZeneca, Plc. Business Overview
11.1.3 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.1.4 AstraZeneca, Plc. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
11.1.5 AstraZeneca, Plc. Recent Development
11.2 Addex Therapeutics
11.2.1 Addex Therapeutics Company Details
11.2.2 Addex Therapeutics Business Overview
11.2.3 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.2.4 Addex Therapeutics Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
11.2.5 Addex Therapeutics Recent Development
11.3 Takeda Pharmaceutical Company Limited
11.3.1 Takeda Pharmaceutical Company Limited Company Details
11.3.2 Takeda Pharmaceutical Company Limited Business Overview
11.3.3 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.3.4 Takeda Pharmaceutical Company Limited Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
11.3.5 Takeda Pharmaceutical Company Limited Recent Development
11.4 Rottapharm (Meda AB)
11.4.1 Rottapharm (Meda AB) Company Details
11.4.2 Rottapharm (Meda AB) Business Overview
11.4.3 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.4.4 Rottapharm (Meda AB) Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
11.4.5 Rottapharm (Meda AB) Recent Development
11.5 Pfizer, Inc.
11.5.1 Pfizer, Inc. Company Details
11.5.2 Pfizer, Inc. Business Overview
11.5.3 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.5.4 Pfizer, Inc. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
11.5.5 Pfizer, Inc. Recent Development
11.6 Eisai Co. Ltd.
11.6.1 Eisai Co. Ltd. Company Details
11.6.2 Eisai Co. Ltd. Business Overview
11.6.3 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.6.4 Eisai Co. Ltd. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
11.6.5 Eisai Co. Ltd. Recent Development
11.7 The Procter & Gamble Company
11.7.1 The Procter & Gamble Company Company Details
11.7.2 The Procter & Gamble Company Business Overview
11.7.3 The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.7.4 The Procter & Gamble Company Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
11.7.5 The Procter & Gamble Company Recent Development
11.8 Mederi Therapeutics
11.8.1 Mederi Therapeutics Company Details
11.8.2 Mederi Therapeutics Business Overview
11.8.3 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.8.4 Mederi Therapeutics Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
11.8.5 Mederi Therapeutics Recent Development
11.9 Aros Pharma
11.9.1 Aros Pharma Company Details
11.9.2 Aros Pharma Business Overview
11.9.3 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.9.4 Aros Pharma Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
11.9.5 Aros Pharma Recent Development
11.10 Torax Medical, Inc.
11.10.1 Torax Medical, Inc. Company Details
11.10.2 Torax Medical, Inc. Business Overview
11.10.3 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.10.4 Torax Medical, Inc. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
11.10.5 Torax Medical, Inc. Recent Development
11.11 BD
11.11.1 BD Company Details
11.11.2 BD Business Overview
11.11.3 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.11.4 BD Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
11.11.5 BD Recent Development
11.12 EndoGastric Solutions
11.12.1 EndoGastric Solutions Company Details
11.12.2 EndoGastric Solutions Business Overview
11.12.3 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.12.4 EndoGastric Solutions Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
11.12.5 EndoGastric Solutions Recent Development
11.13 Medigus Ltd.
11.13.1 Medigus Ltd. Company Details
11.13.2 Medigus Ltd. Business Overview
11.13.3 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.13.4 Medigus Ltd. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
11.13.5 Medigus Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Astrazeneca plc
Addex Therapeutics
Takeda Pharmaceutical Company Limited
Rottapharm (Meda AB)
Pfizer Inc
Eisai Co Ltd
The Procter& Gamble Company
Mederi Therapeutics
Aros Pharma
Torax Medical, Inc.
BD
EndoGastric Solutions
Medigus
List of Tables
 Table 1. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Medication
 Table 3. Key Players of Minimally Invasive Surgery
 Table 4. Key Players of Invasive Surgery
 Table 5. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Region (2020-2025)
 Table 9. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Region (2026-2031)
 Table 11. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Trends
 Table 12. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Drivers
 Table 13. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Challenges
 Table 14. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Restraints
 Table 15. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Players (2020-2025)
 Table 17. Global Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices as of 2024)
 Table 18. Ranking of Global Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Gastroesophageal Reflux Disease (GERD) Drugs and Devices, Headquarters and Area Served
 Table 21. Global Key Players of Gastroesophageal Reflux Disease (GERD) Drugs and Devices, Product and Application
 Table 22. Global Key Players of Gastroesophageal Reflux Disease (GERD) Drugs and Devices, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Type (2020-2025)
 Table 26. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Type (2026-2031)
 Table 28. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Application (2020-2025)
 Table 30. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Application (2026-2031)
 Table 32. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2026-2031) & (US$ Million)
 Table 47. AstraZeneca, Plc. Company Details
 Table 48. AstraZeneca, Plc. Business Overview
 Table 49. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
 Table 50. AstraZeneca, Plc. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025) & (US$ Million)
 Table 51. AstraZeneca, Plc. Recent Development
 Table 52. Addex Therapeutics Company Details
 Table 53. Addex Therapeutics Business Overview
 Table 54. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
 Table 55. Addex Therapeutics Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025) & (US$ Million)
 Table 56. Addex Therapeutics Recent Development
 Table 57. Takeda Pharmaceutical Company Limited Company Details
 Table 58. Takeda Pharmaceutical Company Limited Business Overview
 Table 59. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
 Table 60. Takeda Pharmaceutical Company Limited Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025) & (US$ Million)
 Table 61. Takeda Pharmaceutical Company Limited Recent Development
 Table 62. Rottapharm (Meda AB) Company Details
 Table 63. Rottapharm (Meda AB) Business Overview
 Table 64. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
 Table 65. Rottapharm (Meda AB) Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025) & (US$ Million)
 Table 66. Rottapharm (Meda AB) Recent Development
 Table 67. Pfizer, Inc. Company Details
 Table 68. Pfizer, Inc. Business Overview
 Table 69. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
 Table 70. Pfizer, Inc. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025) & (US$ Million)
 Table 71. Pfizer, Inc. Recent Development
 Table 72. Eisai Co. Ltd. Company Details
 Table 73. Eisai Co. Ltd. Business Overview
 Table 74. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
 Table 75. Eisai Co. Ltd. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025) & (US$ Million)
 Table 76. Eisai Co. Ltd. Recent Development
 Table 77. The Procter & Gamble Company Company Details
 Table 78. The Procter & Gamble Company Business Overview
 Table 79. The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
 Table 80. The Procter & Gamble Company Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025) & (US$ Million)
 Table 81. The Procter & Gamble Company Recent Development
 Table 82. Mederi Therapeutics Company Details
 Table 83. Mederi Therapeutics Business Overview
 Table 84. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
 Table 85. Mederi Therapeutics Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025) & (US$ Million)
 Table 86. Mederi Therapeutics Recent Development
 Table 87. Aros Pharma Company Details
 Table 88. Aros Pharma Business Overview
 Table 89. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
 Table 90. Aros Pharma Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025) & (US$ Million)
 Table 91. Aros Pharma Recent Development
 Table 92. Torax Medical, Inc. Company Details
 Table 93. Torax Medical, Inc. Business Overview
 Table 94. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
 Table 95. Torax Medical, Inc. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025) & (US$ Million)
 Table 96. Torax Medical, Inc. Recent Development
 Table 97. BD Company Details
 Table 98. BD Business Overview
 Table 99. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
 Table 100. BD Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025) & (US$ Million)
 Table 101. BD Recent Development
 Table 102. EndoGastric Solutions Company Details
 Table 103. EndoGastric Solutions Business Overview
 Table 104. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
 Table 105. EndoGastric Solutions Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025) & (US$ Million)
 Table 106. EndoGastric Solutions Recent Development
 Table 107. Medigus Ltd. Company Details
 Table 108. Medigus Ltd. Business Overview
 Table 109. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
 Table 110. Medigus Ltd. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025) & (US$ Million)
 Table 111. Medigus Ltd. Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Picture
 Figure 2. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Type: 2024 VS 2031
 Figure 4. Medication Features
 Figure 5. Minimally Invasive Surgery Features
 Figure 6. Invasive Surgery Features
 Figure 7. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application: 2024 VS 2031
 Figure 9. Heartburn Case Studies
 Figure 10. Acid reflux disorders Case Studies
 Figure 11. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Report Years Considered
 Figure 12. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Region: 2024 VS 2031
 Figure 15. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Players in 2024
 Figure 16. Global Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in 2024
 Figure 18. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Country (2020-2031)
 Figure 20. United States Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Country (2020-2031)
 Figure 24. Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Region (2020-2031)
 Figure 32. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Country (2020-2031)
 Figure 40. Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Country (2020-2031)
 Figure 44. Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. AstraZeneca, Plc. Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
 Figure 48. Addex Therapeutics Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
 Figure 49. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
 Figure 50. Rottapharm (Meda AB) Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
 Figure 51. Pfizer, Inc. Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
 Figure 52. Eisai Co. Ltd. Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
 Figure 53. The Procter & Gamble Company Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
 Figure 54. Mederi Therapeutics Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
 Figure 55. Aros Pharma Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
 Figure 56. Torax Medical, Inc. Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
 Figure 57. BD Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
 Figure 58. EndoGastric Solutions Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
 Figure 59. Medigus Ltd. Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

GERD Drug and Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastroesophageal Reflux Disease Device Market Research Report 2024
Gastroesophageal Reflux Disease GERD Diagnosis Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastroesophageal Reflux Drugs Market
Esophageal Dilator Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastroesophageal Reflux Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastrointestinal Endoscopy Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastro Esophageal Reflux Disease GERD Drug Market Research Report 2025
Gastro Esophageal Reflux Disease Drug and Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Endoscopic Market Research Report 2024
Cardiopulmonary Ventilators Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nasogastric Tube Holder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastric Pump Market Research Report 2025
Global Anti Reflux Device Market Research Report 2024
Global Transesophageal Echocardiography System Market Research Report 2025
Heart Valve Medical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Heart Failure CHF Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
0 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiovascular Medical Device and Diagnostics Trials Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Endoscopy Medical Device Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions